M A Escobar1, N G Saravia, K A Weigle. Show Affiliations » 1. Department of Medicine, University of Connecticut Health Center, Farmington 06030, USA.
Abstract
Entities: Disease
Mesh: See more » AnimalsAntibiotics, Antitubercular/therapeutic useAntitubercular Agents/therapeutic useContraindicationsDrug Therapy, CombinationHumansImmunity, CellularIsoniazid/therapeutic useLeishmania/drug effectsLeishmaniasis, Mucocutaneous/complicationsLeishmaniasis, Mucocutaneous/diagnosisLeishmaniasis, Mucocutaneous/drug therapyMaleMeglumineMeglumine AntimoniateMiddle AgedOrganometallic CompoundsPyrazinamide/therapeutic useRifampin/therapeutic useSputum/microbiologyStreptomycin/therapeutic useTuberculosis, Pulmonary/complicationsTuberculosis, Pulmonary/diagnosisTuberculosis, Pulmonary/drug therapy
Substances: See more » Antibiotics, AntitubercularAntitubercular AgentsOrganometallic CompoundsPyrazinamideMeglumineMeglumine AntimoniateIsoniazidRifampinStreptomycin
Year: 1996 PMID: 8909860 DOI: 10.1093/clinids/23.4.836
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079